| 发明名称 | Method for treating diabetes | ||
| 摘要 | Methods for reducing body weight, altering body composition, treating diabetes, reducing HbA1c and reducing average daily blood glucose by the use of exendins, exendin agonists or exendin analog agonists are provided. | ||
| 申请公布号 | US8906851(B2) | 申请公布日期 | 2014.12.09 |
| 申请号 | US201213708474 | 申请日期 | 2012.12.07 |
| 申请人 | Amylin Pharmaceuticals, LLC;AstraZeneca Pharmaceuticals LP | 发明人 | Fineman Mark;MacConell Leigh;Taylor Kristin |
| 分类号 | A61P3/08;A61P3/10;A61K38/26;C07K14/46;A61K9/00 | 主分类号 | A61P3/08 |
| 代理机构 | Womble Carlyle Sandridge & Rice LLP | 代理人 | Womble Carlyle Sandridge & Rice LLP |
| 主权项 | 1. A method for treating diabetes in a human in need thereof comprising administering once weekly to the human a therapeutically effective amount of a pharmaceutical composition comprising exendin-4 to achieve a mean steady state plasma concentration of the exendin-4 of at least 170 pg/ml for at least one month in the human to treat diabetes, wherein the pharmaceutical composition further comprises a sugar. | ||
| 地址 | San Diego CA US | ||